356 related articles for article (PubMed ID: 27389320)
1. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.
Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y
Andrologia; 2017 May; 49(4):. PubMed ID: 27389320
[TBL] [Abstract][Full Text] [Related]
2. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and longevity.
Comhaire F
Andrologia; 2016 Feb; 48(1):65-8. PubMed ID: 25892327
[TBL] [Abstract][Full Text] [Related]
4. Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population.
Zhang XW; Liu ZH; Hu XW; Yuan YQ; Bai WJ; Wang XF; Shen H; Zhao YP
Chin Med J (Engl); 2012 Nov; 125(21):3806-10. PubMed ID: 23106878
[TBL] [Abstract][Full Text] [Related]
5. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
6. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
[TBL] [Abstract][Full Text] [Related]
7. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
[TBL] [Abstract][Full Text] [Related]
8. [Effect and safety of testosterone undecanoate in the treatment of late-onset hypogonadism: a meta-analysis].
Zheng Y; Shen XB; Zhou YZ; Ma J; Shang XJ; Shi YJ
Zhonghua Nan Ke Xue; 2015 Mar; 21(3):263-71. PubMed ID: 25898560
[TBL] [Abstract][Full Text] [Related]
9. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
[TBL] [Abstract][Full Text] [Related]
11. Testosterone treatment in the aging male: myth or reality?
Nigro N; Christ-Crain M
Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
[TBL] [Abstract][Full Text] [Related]
12. The andrologist's contribution to a better life for ageing men: part 1.
Comhaire F; Mahmoud A
Andrologia; 2016 Feb; 48(1):87-98. PubMed ID: 26395199
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
14. Review of Testim gel.
McNicholas T; Ong T
Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
[TBL] [Abstract][Full Text] [Related]
15. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
Yassin AA; Nettleship JE; Salman M; Almehmadi Y
Andrologia; 2017 May; 49(4):. PubMed ID: 27400881
[TBL] [Abstract][Full Text] [Related]
16. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men.
Lašaitė L; Čeponis J; Preikša RT; Žilaitienė B
Andrologia; 2017 Apr; 49(3):. PubMed ID: 27545990
[TBL] [Abstract][Full Text] [Related]
17. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Testosterone Treatment in Hemodialysis Patients as Assessed by Aging Males' Symptoms Scores: A Pilot Study.
Inoue Y; Nakamura K; Kuwahara Y; Lu Y; Masuda N; Horie S; Okada H; Ide H
Am J Mens Health; 2018 Sep; 12(5):1541-1547. PubMed ID: 29720027
[TBL] [Abstract][Full Text] [Related]
19. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
Brunton SA; Sadovsky R
J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
[TBL] [Abstract][Full Text] [Related]
20. [Hormone replacement therapy in men: practical aspects].
Gamidov SI; Shcherbakov DV; Tazhetdinov OKh; Pavlovichev AA; Iremashvili VV
Urologiia; 2011; (4):68, 70-3. PubMed ID: 22066247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
